15 16 17 18 19 20 21 22 23 24 25 Legends to tables 26 27 Table 1: Characteristic of three studies evaluating TML in Down Syndrome. 28 29 Table 2: Characteristics of two studies evaluating TML in McCune Albright 30 31 Syndrome. 32 33 Table 3: Characteristics of studies evaluating TML in Cryptorchidism. 34 35 Table 4: Characteristics of studies evaluating TML and male infertility. 36 37 Table 5: Cancer subtypes reported in patients with testicular tumours and TML 38 39 Table 6: Characteristics of studies evaluating TML in males with familiar disposition 40 41 to testicular malignancy. 42 43 44 45 46 47 48 49
15 16 17 18 19 20 21 22 23 24 25 26 Legends to tables 27 28 Table 1: Characteristic of three studies evaluating TML in Down Syndrome. 29 30 Table 2: Characteristics of two studies evaluating TML in McCune Albright 31 32 Syndrome. 33 34 Table 3: Characteristics of studies evaluating TML in Cryptorchidism. 35 36 Table 4: Characteristics of studies evaluating TML and male infertility. 37 38 Table 5: Cancer subtypes reported in patients with testicular tumours and TML 39 40 Table 6: Characteristics of studies evaluating TML in males with familiar disposition 41 42 to testicular malignancy. 43 44 45 46 47 48 49
UROL_D_15_01157_R4.docx